SARS-CoV-2 nsp13-IN-1 |
| Catalog No.GC69861 |
SARS-CoV-2 nsp13-IN-1 (composé C1) est un inhibiteur efficace de la nsp13 (protéine non structurale 13). SARS-CoV-2 nsp13-IN-1 ne bloque que l'ATPase ssDNA+ de la nsp13, avec une IC50 de 6 μM. SARS-CoV-2 nsp13-IN-1 ne bloque pas l'ATPase ssDNA-. SARS-CoV-2 nsp13-IN-1 peut être utilisé dans la recherche sur COVID-19.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1005304-44-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for SARS-CoV-2 nsp13-IN-1
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for SARS-CoV-2 nsp13-IN-1
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *